JPMorgan lowered the firm’s price target on Braskem (BAK) to $5 from $6 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAK:
- Braskem Continues Stake Sale Talks with Petroquímica Verde
- Braskem’s Credit Rating Downgraded by Fitch Amid Industry Challenges
- Braskem Initiates Asset Discussions with Unipar
- Braskem S.A. Reports Q2 2025 Financial Results
- Braskem S.A. Files Form 6-K with SEC Detailing Future Outlook Amid Challenges